期刊的影响因子--文章列表

期刊文章列表
Jiahui He¹，Yuyue Zhang¹，Xinge Yu^1,2，Chenjie Xu¹（Department of Biomedical Engineering，City University of Hong Kong；Hong Kong Centre for Cerebro-Cardiovascular Health Engineering）.Wearable patches for transdermal drug delivery[J].Acta Pharmaceutica Sinica B,2023,第6期 Lingling Zhu¹，Xianzhe Yu，Ting Cao³，Hanyu Deng¹，Xiaojun Tang¹，Qing Lin¹，Qinghua Zhou¹（Lung Cancer Center/Lung Cancer Institute，West China Hospital & West China School of Pharmacy，Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan University；Department of Gastrointestinal Surgery，Chengdu Second People’s Hospital；Laboratory of Infectious Diseases and Vaccine，West China Hospital，Sichuan University）.Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis[J].Acta Pharmaceutica Sinica B,2023,第6期 Tao Liang^1,2，Fengli Wang³，Reham M.Elhassan²，Yongmei Cheng¹，Xiaolei Tang^3,4，Wengang Chen¹，Hao Fang²，Xuben Hou²（Department of Pharmacy，the Second Hospital Affiliated Wannan Medical College；Department of Medicinal Chemistry and Key Laboratory of Chemical Biology(Ministry of Education)，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University；Department of Science and Education，Translational Medicine Center & Vascular Disease Research Center，the Second Hospital Affiliated Wannan Medical College；Clinical Pathogens Detection Engineering Center of Wuhu）.Targeting histone deacetylases for cancer therapy：Trends and challenges[J].Acta Pharmaceutica Sinica B,2023,第6期 Jialu Wu^1,2，Yue Wan³，Zhenxing Wu^1,2，Shengyu Zhang³，Dongsheng Cao⁴，Chang-Yu Hsieh¹，Tingjun Hou¹（Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University，College of Pharmaceutical Sciences，Zhejiang University；Carbon Silicon AI Technology Co.，Ltd.；Tencent Quantum Laboratory；Xiangya School of Pharmaceutical Sciences，Central South University）.MF-SuP-pK_a：Multi-fidelity modeling with subgraph pooling mechanism for pK_a prediction[J].Acta Pharmaceutica Sinica B,2023,第6期 Gaona Shi¹，Yu Zhou¹，Wenshuai Liu²，Chengjuan Chen¹，Yazi Wei¹，Xinlong Yan³，Lei Wu¹，Weiwei Wang²，Lan Sun¹，Tiantai Zhang¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；Tianjin Key Laboratory of Biomaterial Research，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences & Peking Union Medical College；Faculty of Environmental and Life Sciences，Beijing University of Technology）.Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A_2A/2B receptors in tolerogenic dendritic cells[J].Acta Pharmaceutica Sinica B,2023,第6期 Guangsheng Du，Ming Qin，Xun Sun（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Recent progress in application of nanovaccines for enhancing mucosal immune responses[J].Acta Pharmaceutica Sinica B,2023,第6期 Yuehong Ren¹，Wei Wu^2,3，Xingwang Zhang¹（Department of Pharmaceutics，College of Pharmacy，Jinan University；Center for Medical Research and Innovation，Shanghai Pudong Hospital，Fudan University Pudong Medical Center；Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University）.The feasibility of oral targeted drug delivery：Gut immune to particulates?[J].Acta Pharmaceutica Sinica B,2023,第6期 Jianping Ye（Metabolic Disease Research Center，Zhengzhou University Affiliated Zhengzhou Central Hospital；Center for Advanced Medicine，College of Medicine，Zhengzhou University；Research Center of Basic Medicine，Academy of Medical Sciences，Zhengzhou University）.Commentary：Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes[J].Acta Pharmaceutica Sinica B,2023,第6期 Jing Chen¹，Peng Ji¹，Giri Gnawali¹，Mengyang Chang²，Feng Gao¹，Hang Xu¹，Wei Wang^1,2,3（Department of Pharmacology and Toxicology，University of Arizona；Department of Chemistry and Biochemistry，University of Arizona；BIO5 Institute，and University of Arizona Cancer Center，University of Arizona）.Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery[J].Acta Pharmaceutica Sinica B,2023,第6期 Bingbing Li¹，Chao Teng²，Huiling Yu^1,3，Xiaohong Jiang²，Xuyang Xing²，Qi Jiang²，Chenshi Lin²，Zongmin Zhao⁴，Ruifeng Zhang⁵，Wei He^2,6（Department of Anesthesiology，Affiliated Drum Tower of Nanjing University；School of Pharmacy，China Pharmaceutical University；Department of Anesthesiology，Women's Hospital of Nanjing Medical University，Nanjing Maternity and Child Health Care Hospital；Department of Pharmaceutical Sciences，College of Pharmacy，University of Illinois at Chicago；Department of Respiratory Medicine，Zhongda Hospital of Southeast University；Shanghai Skin Disease Hospital，Tongji University School of Medicine）.Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries[J].Acta Pharmaceutica Sinica B,2023,第6期 Chao Chen¹，Wu Zhong²，Shiyu Du¹，Yayao Li¹，Yunfei Zeng²，Kunguo Liu¹，Jingjing Yang¹，Xiaoxiang Guan³，Xin Han¹（Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization，School of Medicine & Holistic Integrative Medicine，Nanjing University of Chinese Medicine；Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province，School of Medicine，Hunan Normal University；Department of Oncology，the First Affiliated Hospital of Nanjing Medical University）.Intelligent nanotherapeutic strategies for the delivery of CRISPR system[J].Acta Pharmaceutica Sinica B,2023,第6期 Xiaomin Wang^1,2，Jun Xu^1,2，Yiming Sun¹，Siyuwei Cao¹，Hanlin Zeng¹，Nan Jin¹，Matthew Shou³，Shuai Tang¹，Yi Chen^1,2，Min Huang^1,2,4（Cancer Research Center，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Division of Diabetes，Endocrinology and Metabolism，Department of Molecular Physiology and Biophysics，Vanderbilt University Medical Center；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences）.Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer[J].Acta Pharmaceutica Sinica B,2023,第6期 Qian Yu^1,2，Chang Li^2,3，Qinghui Niu⁴，Jigang Wang⁵，Zhaodi Che⁶，Ke Lei¹，He Ren¹，Boyi Ma¹，Yixing Ren⁷，Pingping Luo⁶，Zhuming Fan²，Huan Zhang^8,9，Zhaohui Liu³，George L.Tipoe²，Jia Xiao^6,7（Tumor Immunology and Cytotherapy of Medical Research Center，and Center for GI Cancer Diagnosis and Treatment，the Affiliated Hospital of Qingdao University；Bau Institute of Medical and Health Sciences Education and School of Biomedical Sciences，LKS Faculty of Medicine，the University of Hong Kong；School of Biomedical Sciences，the Chinese University of Hong Kong；Department of Liver Center，the Affiliated Hospital of Qingdao University；Department of Pathology，the Affiliated Hospital of Qingdao University；Clinical Medicine Research Institute and Department of Metabolic and Bariatric Surgery，the First Affiliated Hospital of Jinan University；Department of General Surgery，and Institute of Hepato-Biliary-Pancreas and Intestinal Disease，Affiliated Hospital of North Sichuan Medical College；Department of Applied Biology and Chemical Technology，the Hong Kong Polytechnic University；Research Center for Chinese Medicine Innovation，the Hong Kong Polytechnic University）.Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis[J].Acta Pharmaceutica Sinica B,2023,第6期 Yaochen Xie¹，Qian Zhou²，Qiaojun He¹，Xiaoyi Wang，Jincheng Wang¹（Center for Drug Safety Evaluation and Research，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；Department of Pharmacy，Hangzhou Medical College；Department of Nephrology，the First Affiliated Hospital of Huzhou Teachers College，the First People’s Hospital of Huzhou）.Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition[J].Acta Pharmaceutica Sinica B,2023,第6期 Jiayi Luan¹，Ruotao Li²，Weiguo Xu³，Huiying Sun¹，Qiqi Li¹，Di Wang¹，Shujun Dong¹，Jianxun Ding³（VIP Integrated Department，Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling，School and Hospital of Stomatology，Jilin University；Department of Hand and Foot Surgery，the First Hospital of Jilin University；Key Laboratory of Polymer Ecomaterials，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences）.Functional biomaterials for comprehensive periodontitis therapy[J].Acta Pharmaceutica Sinica B,2023,第6期 Lijuan Ma¹，Boyi Li²，Jinchen Ma²，Chunyuan Wu³，Nan Li^1,4，Kailin Zhou⁵，Yun Yan²，Mingshuang Li¹，Xiaoyan Hu¹，Hao Yan¹，Qi Wang²，Yanfei Zheng²，Zhisheng Wu^1,4（Beijing University of Chinese Medicine，School of Chinese Materia Medica；Beijing University of Chinese Medicine，School of Traditional Chinese Medicine；Shanghai New Asiatic Pharmaceuticals Hanjiang Co.，Ltd.；Engineering Research Center of Ministry of Education for Traditional Chinese Medicine Pharmaceutical and New Drug Development；Beijing University of Chinese Medicine，School of Humanities）.Novel discovery of schisandrin A regulating the interplay of autophagy and apoptosis in oligoasthenospermia by targeting SCF/c-kit and TRPV1 via biosensors[J].Acta Pharmaceutica Sinica B,2023,第6期 Pengyun Li^1,2，Changkai Jia^1,2，Zhiya Fan³，Xiaotong Hu¹，Wenjuan Zhang¹，Ke Liu²，Shiyang Sun¹，Haoxin Guo⁴，Ning Yang¹，Maoxiang Zhu⁴，Xiaomei Zhuang²，Junhai Xiao^1,2，Zhibing Zheng^1,2，Song Li^1,2（National Engineering Research Center for Strategic Drugs，Beijing Institute of Pharmacology and Toxicology Institution；State Key Laboratory of Toxicology and Medical Countermeasures，Beijing Institute of Pharmacology and Toxicology；National Center for Protein Sciences(Beijing)，Beijing Institute of Lifeomics，State Key Laboratory of Proteomics，Beijing Proteome Research Center；Beijing Key Laboratory for Radiobiology，Beijing Institute of Radiation Medicine）.Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations[J].Acta Pharmaceutica Sinica B,2023,第6期 Bingwei Wang¹，Yan Ma¹，Sheng Li²，Hang Yao²，Mingna Gu¹，Ying Liu¹，You Xue¹，Jianhua Ding²，Chunmei Ma²，Shuo Yang²，Gang Hu^1,2（School of Medicine & Holistic Integrative Medicine，Nanjing University of Chinese Medicine；School of Basic Medical Sciences，Nanjing Medical University）.GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson’s disease[J].Acta Pharmaceutica Sinica B,2023,第6期 Wenxin Zhang¹，Xiaohui Pan¹，Yanjun Xu²，Hongjie Guo¹，Mingming Zheng¹，Xi Chen¹，Honghai Wu¹，Fengming Luan³，Qiaojun He^1,4,5，Ling Ding¹，Bo Yang^1,4（Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，Institute of Pharmacology and Toxicology，College of Pharmaceutical Sciences，Zhejiang University；Department of Medical Thoracic Oncology，the Cancer Hospital of University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)，Chinese Academy of Sciences；Department of Gastrointestinal Surgery，Second Affiliated Hospital of Zhejiang University，School of Medicine；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center of Zhejiang University）.Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA[J].Acta Pharmaceutica Sinica B,2023,第6期 Nan Ru¹，Wan-Yang Sun¹，Hua-Jun Wang¹，Yan-Ping Wu¹，Xiao-Fei Zheng¹，Rong-Rong He^1,2（The First Affiliated Hospital/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education(MOE)/Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research，Jinan University；State Key Laboratory of Quality Research in Chinese Medicine，Macau University of Science and Technology）.Commentary：A nearly forgotten class of anti-inflammatory lipid molecules in central nervous system[J].Acta Pharmaceutica Sinica B,2023,第6期 Wei He^1,2，Alejandro Sosnik³，Chenjie Xu⁴（School of Pharmacy，China Pharmaceutical University；Shanghai Skin Disease Hospital，Tongji University School of Medicine；Laboratory of Pharmaceutical Nanomaterials Science，Department of Materials Science and Engineering，Technion-Israel Institute of Technology；Department of Biomedical Engineering，City University of Hong Kong）.Editorial of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection[J].Acta Pharmaceutica Sinica B,2023,第6期 Yue Chen¹，Jianing Song²，Yihang Cui²，Liyun Zhou²（Dongzhimen Hospital，Beijing University of Chinese Medicine；Pharmcube (Beijing) Co.，Ltd.）.Five trends of China’s pharmaceutical industry in 2022[J].Acta Pharmaceutica Sinica B,2023,第6期 Jie Chen，Xiaohong Wei，Qian Zhang，Yuzhuo Wu，Guiyang Xia，Huan Xia，Lingyan Wang，Hongcai Shang，Sheng Lin（Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing，Dongzhimen Hospital，Beijing University of Chinese Medicine）.The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms[J].Acta Pharmaceutica Sinica B,2023,第5期 Chuanfeng Tang¹，Qiaona Wang¹，Jingyan Shen¹，Congying Wang¹，Hong Ding¹，Shiyu Wen¹，Fan Yang¹，Ruiqing Jiao¹，Xingxin Wu¹，Jianmei Li¹，Lingdong Kong^1,2（State Key Laboratory of Pharmaceutical Biotechnology，School of Life Sciences，Nanjing University；State Key Laboratory of Natural Medicines，China Pharmaceutical University）.Neuron stem cell NLRP6 sustains hippocampal neurogenesis to resist stress-induced depression[J].Acta Pharmaceutica Sinica B,2023,第5期 Fuhua Wu，Shuang Luo，Yongshun Zhang，Yangsen Ou，Hairui Wang，Zhaofei Guo，Chunting He，Shuting Bai，Penghui He，Min Jiang，Xiaoyan Chen，Guangsheng Du，Xun Sun（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity[J].Acta Pharmaceutica Sinica B,2023,第5期 Duo Xu^1,2,3，Fan Yang^2,3，Jiayao Chen^1,3，Tianxing Zhu^2,3，Fen Wang⁴，Yitai Xiao^2,3，Zibin Liang³，Lei Bi³，Guolong Huang³，Zebo Jiang^2,3，Hong Shan^1,3，Dan Li^2,3（Center for Interventional Medicine，the Fifth Affiliated Hospital，Sun Yat-sen University；Department of Nuclear Medicine，the Fifth Affiliated Hospital，Sun Yat-sen University；Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging，the Fifth Affiliated Hospital，Sun Yat-sen University；Department of Pathology，the First Affiliated Hospital，Sun Yat-sen University）.Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury[J].Acta Pharmaceutica Sinica B,2023,第5期 Yonghyun Choi¹，Wooic Son^2,3，Youngpin Han^2,3，Jayoung Chae¹，Chul-Su Yang^2,3，Jonghoon Choi¹（School of Integrative Engineering，Chung-Ang University；Department of Molecular & Life Science，Hanyang University；Center for Bionano Intelligence Education and Research，Hanyang University）.Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma[J].Acta Pharmaceutica Sinica B,2023,第5期 Chuan Hu，Yujun Song，Yiwei Zhang，Siqin He，Xueying Liu，Xiaotong Yang，Tao Gong，Yuan Huang，Huile Gao（Key Laboratory of Drug Targeting and Drug Delivery Systems，West China School of Pharmacy，Sichuan University）.Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome[J].Acta Pharmaceutica Sinica B,2023,第5期 Boya Chen¹，Haiying Zhu¹，Bo Yang^1,2，Ji Cao^1,2,3（Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center of Zhejiang University）.The dichotomous role of immunoproteasome in cancer：Friend or foe?[J].Acta Pharmaceutica Sinica B,2023,第5期首页上一页 4 5 6 7 8 下一页尾页共有11页，转到页

期刊文章列表